Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Exelixis Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Exelixis Inc. May 31, 202386.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Exelixis Inc. | Grant or award | +8,367 | — | — |
| Apr 7, 2026 | Ovid Therapeutics Inc. | Grant or award | +17,578 | $2.56 | $45,000 |
| Nov 12, 2025 | Exelixis Inc. | Open-market sale | −100,000 | $43.55 | $4,355,000 |
| May 29, 2025 | Exelixis Inc. | Grant or award | +9,812 | — | — |
| May 15, 2025 | Exelixis Inc. | Option exercise | +20,634 | $19.77 | $407,934 |
| May 15, 2025 | Exelixis Inc. | Open-market sale | −20,634 | $44.35 | $915,118 |
| May 15, 2025 | Exelixis Inc. | Option exercise | +15,874 | $20.50 | $325,417 |
| May 15, 2025 | Exelixis Inc. | Open-market sale | −15,874 | $44.35 | $704,012 |
| May 31, 2024 | Exelixis Inc. | Grant or award | +18,838 | — | — |
| May 20, 2024 | Exelixis Inc. | Option exercise | +11,686 | $19.57 | $228,695 |
| May 20, 2024 | Exelixis Inc. | Open-market sale | −11,437 | $21.00 | $240,177 |
| Jun 1, 2023 | Exelixis Inc. | Grant or award | +20,718 | — | — |
Questions about Stelios Papadopoulos
What boards is Stelios Papadopoulos on?
Stelios Papadopoulos sits on the boards of Exelixis Inc. and Ovid Therapeutics Inc.
How long has Stelios Papadopoulos served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.